Welcome
Support Centre
19 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A 2 x 2 randomised, double blind, placebo controlled trial of pentoxifylline (trental) +/- high dose vitamins for radiation induced bowel toxicity: the ROBOTS 2 trial
ISRCTN ISRCTN33398289
ClinicalTrials.gov identifier
Public title A 2 x 2 randomised, double blind, placebo controlled trial of pentoxifylline (trental) +/- high dose vitamins for radiation induced bowel toxicity: the ROBOTS 2 trial
Scientific title
Acronym ROBOTS 2 (Relief Of BOwel Toxicity Study 2)
Serial number at source N0258134912
Study hypothesis This would be the first randomised trial addressing this issue in patients with bowel symptoms after radiotherapy.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Injury, Occupational Diseases, Poisoning: Radiation injuries
Participants - inclusion criteria 1. Patients referred at least three months after pelvic radiotherapy
2. Patients must have gastrointestinal symptoms which were not present before radiotherapy
3. Must have undergone adequate gastroenterological assessment to reach a diagnosis
4. Must have residual gastrointestinal symptoms after three months of best therapy
Participants - exclusion criteria 1. Previous cerebrovascular haemorrhage
2. Previous retinal haemorrhage
3. Liver cirrhosis
4. Symptomatic coronary artery disease
5. Abnormal renal function and creatine clearance
6. History of renal tract stone
7. Evidence of recurrent disease
Anticipated start date 26/03/2004
Anticipated end date 13/04/2008
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Patients will be randomised in a 2 x 2 factorial fashion to:
1. Pentoxifylline (trental)
2. High dose vitamins
3. Pentoxifylline (trental) with high dose vitamins
4. Placebo
Primary outcome measure(s) 1. Changes in the bowel toxicity scale Inflammatory Bowel Disease Questionnaire (IBDQ)
2. Changes in the Vaizey incontinence questionnaire
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. The Royal Marsden NHS Foundation Trust (UK)
2. NHS R&D Support Funding (UK)
Trial website
Publications
Contact name Dr  Jervoise  Andreyev
  Address Medicine Section
Royal Marsden NHS Trust
Downs Road
  City/town Sutton, Surrey
  Zip/Postcode SM2 5PT
  Country United Kingdom
  Tel +44 (0)20 8643 8901
  Fax +44 (0)20 7808 2048
  Email j.andreyev@imperial.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 14/04/2008
Date ISRCTN assigned 30/09/2005
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central